Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C5a induces tissue factor activity on endothelial cells

K Ikeda1, K Nagasawa, T Horiuchi

  • 1First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

Thrombosis and Haemostasis
|February 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical factors to predict a poor prognosis and refractory disease in patients with polymyositis and dermatomyositis associated with interstitial lung disease.

Clinical and experimental rheumatology·2012
Same author

Analysis of fas ligand gene mutation in patients with systemic lupus erythematosus.

Arthritis and rheumatism·2000
Same author

An NcoI polymorphism in the human complement component 7 (C7) gene.

Journal of human genetics·1999
Same author

Association of Fas/APO-1 gene polymorphism with systemic lupus erythematosus in Japanese.

Rheumatology (Oxford, England)·1999
Same author

Analysis of CD40 ligand gene mutations in patients with primary biliary cirrhosis.

Scandinavian journal of clinical and laboratory investigation·1998
Same author

Genetic basis of human complement C8 alpha-gamma deficiency.

Journal of immunology (Baltimore, Md. : 1950)·1998

Recombinant human C5a significantly increases tissue factor (TF) activity and TF mRNA levels in human umbilical vein endothelial cells (HUVEC). This C5a-induced TF expression, linked to inflammation and coagulation, was reduced by methylprednisolone.

Area of Science:

  • Biochemistry
  • Immunology
  • Cell Biology

Background:

  • Tissue factor (TF) is a key regulator of blood coagulation, acting as a cofactor for factor VIIa.
  • TF expression on endothelial cells can be triggered by inflammatory stimuli like LPS, IL-1β, and TNFα.

Purpose of the Study:

  • To investigate the effect of recombinant human C5a on TF activity and expression in human umbilical vein endothelial cells (HUVEC).

Main Methods:

  • Human umbilical vein endothelial cells (HUVEC) were treated with varying concentrations of recombinant human C5a.
  • TF activity was measured, and TF mRNA levels were assessed using RT-PCR.
  • The effect of methylprednisolone on C5a-induced TF activity was evaluated.

Main Results:

Related Experiment Videos

  • Recombinant human C5a induced TF activity in HUVEC in a dose-dependent manner, with peak activity observed 3-6 hours post-treatment.
  • TF mRNA levels significantly increased (3.75-fold) after 3 hours of incubation with C5a, indicating transcriptional regulation.
  • Methylprednisolone inhibited the C5a-mediated induction of TF activity.

Conclusions:

  • C5a is a potent inducer of TF activity and mRNA in HUVEC, suggesting a link between complement activation and the coagulation cascade.
  • The findings highlight a potential mechanism connecting inflammatory pathways (via C5a) with the initiation of blood coagulation.
  • Understanding this interplay may offer insights into thrombotic complications associated with inflammation.